Fig. 1From: Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutationsQuantitaive polymerase chain reaction (qPCR) MET copy number gain (CNG) analysis for 15 casesBack to article page